László Gopcsa

697 total citations
44 papers, 339 citations indexed

About

László Gopcsa is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, László Gopcsa has authored 44 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in László Gopcsa's work include Hematopoietic Stem Cell Transplantation (9 papers), COVID-19 Clinical Research Studies (7 papers) and Acute Myeloid Leukemia Research (7 papers). László Gopcsa is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), COVID-19 Clinical Research Studies (7 papers) and Acute Myeloid Leukemia Research (7 papers). László Gopcsa collaborates with scholars based in Hungary, South Korea and Germany. László Gopcsa's co-authors include Katalin Pálóczi, Éva Rajnavölgyi, Hajnalka Andrikovics, Attila Szabó, Attila Bácsi, Kitti Pázmándi, Tamás Masszi, Árpád Bátai, Zoltán Magyarics and Péter Reményi and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Cancer Immunology Immunotherapy.

In The Last Decade

László Gopcsa

33 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Gopcsa Hungary 13 132 100 92 79 55 44 339
Marguerite Vignon France 10 114 0.9× 102 1.0× 74 0.8× 90 1.1× 51 0.9× 26 324
Sumie Tabata Japan 13 101 0.8× 113 1.1× 137 1.5× 96 1.2× 141 2.6× 49 449
Hajime Yasuda Japan 11 93 0.7× 66 0.7× 111 1.2× 74 0.9× 73 1.3× 55 366
Jeremy Ramdial United States 10 121 0.9× 63 0.6× 129 1.4× 39 0.5× 86 1.6× 62 310
Warda Faridi United States 7 76 0.6× 109 1.1× 121 1.3× 33 0.4× 61 1.1× 13 257
Elizabeth L. Courville United States 11 136 1.0× 64 0.6× 147 1.6× 36 0.5× 108 2.0× 46 376
Yasuyoshi Morita Japan 11 132 1.0× 101 1.0× 51 0.6× 80 1.0× 60 1.1× 53 333
Tadaharu Kanie Japan 10 157 1.2× 108 1.1× 132 1.4× 55 0.7× 62 1.1× 22 369
Masaaki Kume Japan 11 240 1.8× 143 1.4× 80 0.9× 242 3.1× 123 2.2× 27 543
Michihiko Masuda Japan 12 175 1.3× 98 1.0× 117 1.3× 70 0.9× 86 1.6× 27 375

Countries citing papers authored by László Gopcsa

Since Specialization
Citations

This map shows the geographic impact of László Gopcsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Gopcsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Gopcsa more than expected).

Fields of papers citing papers by László Gopcsa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Gopcsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Gopcsa. The network helps show where László Gopcsa may publish in the future.

Co-authorship network of co-authors of László Gopcsa

This figure shows the co-authorship network connecting the top 25 collaborators of László Gopcsa. A scholar is included among the top collaborators of László Gopcsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Gopcsa. László Gopcsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bátai, Árpád, Mónika Fekete, László Gopcsa, et al.. (2024). Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathology & Oncology Research. 30. 1611720–1611720. 5 indexed citations
3.
4.
5.
Szabó, Bálint Gergely, Péter Reményi, László Gopcsa, et al.. (2023). Extracorporeal Photopheresis as a Possible Therapeutic Approach for Adults with Severe and Critical COVID-19 Non-Responsive to Standard Treatment: A Pilot Investigational Study. Journal of Clinical Medicine. 12(15). 5000–5000.
6.
Tóth, Gábor, Gábor László Sándor, Cecília Czakó, et al.. (2022). Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy—Analysis of 130 Eyes of 65 Subjects. Journal of Clinical Medicine. 11(7). 1848–1848. 4 indexed citations
7.
Tóth, Gábor, Gábor László Sándor, Cecília Czakó, et al.. (2021). Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects. Journal of Ophthalmology. 2021. 1–8. 2 indexed citations
8.
Bors, András, László Gopcsa, Gábor Mikala, et al.. (2021). Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia. PLoS ONE. 16(6). e0253386–e0253386. 6 indexed citations
9.
Lakatos, Botond, László Gopcsa, Eszter Molnár, et al.. (2020). Citokinellenes terápia az új típusú koronavírus okozta megbetegedés (COVID–19) kezelésében – tocilizumab elsőként való alkalmazása egy hazai infektológiai osztályon (A COVID–19-pandémia orvosszakmai kérdései). Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 6 indexed citations
10.
Pinczés, László Imre, Árpád Illés, Klára Piukovics, et al.. (2020). Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma. Annals of Hematology. 99(10). 2385–2392. 12 indexed citations
11.
Bors, András, László Gopcsa, Árpád Bátai, et al.. (2019). Investigation of TGFB1 −1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(1). 215–223. 1 indexed citations
12.
Varga, Gergely, Gábor Mikala, László Gopcsa, et al.. (2018). Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature. Journal of Oncology. 2018. 1–7. 28 indexed citations
13.
Andrikovics, Hajnalka, Péter Reményi, Árpád Bátai, et al.. (2015). The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy. Bone Marrow Transplantation. 50(10). 1321–1325. 18 indexed citations
14.
Reményi, Péter, László Gopcsa, Marienn Réti, et al.. (2014). Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF. Advances in Therapy. 31(4). 451–460. 20 indexed citations
15.
Szabó, Attila, Zoltán Magyarics, Kitti Pázmándi, et al.. (2014). TLR ligands upregulate RIG‐I expression in human plasmacytoid dendritic cells in a type I IFN‐independent manner. Immunology and Cell Biology. 92(8). 671–678. 34 indexed citations
16.
Andrikovics, Hajnalka, Árpád Bátai, András Bors, et al.. (2011). The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia. Haematologica. 96(11). 1613–1618. 14 indexed citations
17.
Gopcsa, László, et al.. (2006). Hepatosplenic γδ T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(4). 479–483. 19 indexed citations
18.
Gopcsa, László, Katalin Jakab, András Matolcsy, et al.. (2005). Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells. European Journal Of Haematology. 75(4). 346–351. 24 indexed citations
19.
Varga, Lilian, et al.. (2004). Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas. Cancer Immunology Immunotherapy. 53(9). 835–9. 2 indexed citations
20.
Gopcsa, László, et al.. (2002). Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplantation. 29(5). 449–452. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marguerite Vignon Breakdown of academic impact, for papers by Sumie Tabata Breakdown of academic impact, for papers by Hajime Yasuda Breakdown of academic impact, for papers by Jeremy Ramdial Breakdown of academic impact, for papers by Warda Faridi Breakdown of academic impact, for papers by Elizabeth L. Courville Breakdown of academic impact, for papers by Yasuyoshi Morita Breakdown of academic impact, for papers by Tadaharu Kanie Breakdown of academic impact, for papers by Masaaki Kume Breakdown of academic impact, for papers by Michihiko Masuda
Rankless by CCL
2026